436 related articles for article (PubMed ID: 31005927)
1. Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial.
Chen H; Li N; Shi J; Ren J; Liu C; Zhang Y; Jiang Z; Zhang Z; Dai M
BMJ Open; 2019 Apr; 9(4):e025935. PubMed ID: 31005927
[TBL] [Abstract][Full Text] [Related]
2. A digital intake tool to avert outpatient visits in a FIT-based colorectal cancer screening population: study protocol of a multicentre, prospective non-randomized trial - the DIT-trial.
Marijnissen FE; de Jonge PJF; Erler NS; Ismail SY; Lansdorp-Vogelaar I; Spaander MCW
BMC Gastroenterol; 2024 Jan; 24(1):38. PubMed ID: 38238726
[TBL] [Abstract][Full Text] [Related]
3. Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C).
Chen H; Lu M; Liu C; Zou S; Du L; Liao X; Dong D; Wei D; Gao Y; Zhu C; Zhu L; Zheng W; Xiao H; Kong Y; Yin H; Zhou H; Ying R; Wang B; Zhang J; Zhang X; Zhang Q; Zhang X; Zhang Y; Wang H; Guo L; Liu L; Ren J; Shi J; Li N; Miao X; Brenner H; Dai M
Am J Gastroenterol; 2020 Aug; 115(8):1264-1274. PubMed ID: 32282342
[TBL] [Abstract][Full Text] [Related]
4. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
Steele RJC; Digby J; Chambers JA; O'Carroll RE
BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
[TBL] [Abstract][Full Text] [Related]
5. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
6. Colon capsule endoscopy in colorectal cancer screening: a randomised controlled trial.
Kaalby L; Deding U; Kobaek-Larsen M; Havshoi AV; Zimmermann-Nielsen E; Thygesen MK; Kroeijer R; Bjørsum-Meyer T; Baatrup G
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32601101
[TBL] [Abstract][Full Text] [Related]
7. Participation and yield of a population-based colorectal cancer screening programme in China.
Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
[TBL] [Abstract][Full Text] [Related]
8. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
[TBL] [Abstract][Full Text] [Related]
9. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C).
Chen H; Shi J; Lu M; Li Y; Du L; Liao X; Wei D; Dong D; Gao Y; Zhu C; Ying R; Zheng W; Yan S; Xiao H; Zhang J; Kong Y; Li F; Zou S; Liu C; Wang H; Zhang Y; Lu B; Luo C; Cai J; Tian J; Miao X; Ding K; Brenner H; Dai M
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):808-818. PubMed ID: 35964896
[TBL] [Abstract][Full Text] [Related]
11. Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study.
Dong X; Du L; Luo Z; Xu Y; Wang C; Wang F; Cao W; Zhao L; Zheng Y; Zhu H; Xia C; Li J; Du M; Hang D; Ren J; Shi J; Shen H; Chen W; Li N; He J;
PLoS Med; 2024 Feb; 21(2):e1004340. PubMed ID: 38386617
[TBL] [Abstract][Full Text] [Related]
12. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E;
PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831
[TBL] [Abstract][Full Text] [Related]
13. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).
Saito H; Kudo SE; Takahashi N; Yamamoto S; Kodama K; Nagata K; Mizota Y; Ishida F; Ohashi Y
Int J Colorectal Dis; 2020 May; 35(5):933-939. PubMed ID: 32034490
[TBL] [Abstract][Full Text] [Related]
15. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
[No Abstract] [Full Text] [Related]
16. Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
Ykema BLM; Bisseling TM; Spaander MCW; Moons LMG; van der Biessen-van Beek D; Saveur L; Kerst M; Mulder SF; de Wit R; Zweers D; Meijer GA; Beijnen JH; Lansdorp-Vogelaar I; van Leeuwen FE; Snaebjornsson P; van Leerdam ME
BMC Gastroenterol; 2021 Feb; 21(1):67. PubMed ID: 33579196
[TBL] [Abstract][Full Text] [Related]
17. Korean colonoscopy screening pilot study (K-cospi) for screening colorectal cancer: study protocol for the multicenter, community-based clinical trial.
Park B; Jun JK; Kim BC; Choi KS; Suh M; ; ; ;
BMC Gastroenterol; 2021 Jan; 21(1):36. PubMed ID: 33499810
[TBL] [Abstract][Full Text] [Related]
18. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
19. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants.
Kværner AS; Birkeland E; Bucher-Johannessen C; Vinberg E; Nordby JI; Kangas H; Bemanian V; Ellonen P; Botteri E; Natvig E; Rognes T; Hovig E; Lyle R; Ambur OH; de Vos WM; Bultman S; Hjartåker A; Landberg R; Song M; Blix HS; Ursin G; Randel KR; de Lange T; Hoff G; Holme Ø; Berstad P; Rounge TB
BMC Cancer; 2021 Aug; 21(1):930. PubMed ID: 34407780
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Positivity Thresholds for a Risk-Adapted Screening Strategy in Colorectal Cancer Screening.
Lu M; Wang L; Zhang Y; Liu C; Lu B; Du L; Liao X; Dong D; Wei D; Gao Y; Shi J; Ren J; Chen H; Dai M
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00398. PubMed ID: 34397041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
